Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization

被引:37
作者
Christenson, JT [1 ]
机构
[1] Hop Tour, Dept Cardiovasc Surg & Cardiol, CH-1217 Meyrin, Switzerland
来源
CARDIOVASCULAR SURGERY | 2001年 / 9卷 / 01期
关键词
hypercholesterolemia; lipids; CABG; statins; angiography; follow up; veins; grafts; sequential; internal thoracic artery; arterial anastomosis;
D O I
10.1016/S0967-2109(00)00088-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercholesterolemia is a recognized risk factor for development of atherosclerosis in both native coronary arteries and bypass grafts. Lipid-lowering therapy with statins is effective. Few data are available for studies on bypass grafts. The influence of hypercholesterolemia on development of bypass graft disease was studied. Clinical and angiographic follow up 1 yr after CABG of patients with a preoperative cholesterol > 6.2 mmol/l, with a preoperative lipid control (group 2) or controls (group 1) and patients with cholesterol < 4.7 mmol/l (group 3) were studied. Patient demographics, angiography and operation data-were the same in all the groups. Group 1 patients had significantly higher incidence of graft lesions, requiring more interventions than Group 2, Sequential vein bypass grafts showed superior features compared to single vein grafts. Preoperative lipid control with statins is strongly recommended, since uncontrolled hypercholesterolemia has a direct impact on the outcome of CABG procedure. It significantly reduces the development of vein graft obstructive disease. (C) 2001 The International Society for Cardiovascular Surgery, Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 31 条
[1]   Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering [J].
Azen, SP ;
Qian, DJ ;
Mack, WJ ;
Sevanian, A ;
Selzer, RH ;
Liu, CR ;
Liu, CH ;
Hodis, HN .
CIRCULATION, 1996, 94 (10) :2369-2372
[2]   Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus-apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts [J].
Bjorkerud, B ;
Bjorkerud, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :416-424
[3]  
BLAKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233
[4]  
BOURASSA MG, 1985, CIRCULATION, V72, P71
[5]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[6]   ACCELERATED ATHEROSCLEROSIS - MORPHOLOGIC STUDY OF 97 SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS [J].
BULKLEY, BH ;
HUTCHINS, GM .
CIRCULATION, 1977, 55 (01) :163-169
[7]  
CAMPEAU L, 1983, CIRCULATION, V68, P1
[8]   Sequential vein bypass grafting: tactics and long-term results [J].
Christenson, JT ;
Simonet, F ;
Schmuziger, M .
CARDIOVASCULAR SURGERY, 1998, 6 (04) :389-397
[9]   Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG [J].
Christenson, JT .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 15 (04) :394-399
[10]  
Christenson JT, 1997, ANN THORAC SURG, V63, P371